Literature DB >> 27022816

The patient with anemia.

Aryeh Shander1, Mazyar Javidroozi.   

Abstract

PURPOSE OF REVIEW: Anemia remains a global health issue. This review addresses the recent findings on anemia in surgical patients and its significance in perioperative setting. RECENT
FINDINGS: The prevalence of anemia in surgical populations is high, ranging from one-third of population to nearly 100%. Anemia is an independent, modifiable risk factor for a growing list of unfavorable events, complications and diminished functional outcomes (lasting for months following discharge), as well as a major predisposing factor for allogeneic blood transfusions. Therefore, timely screening and diagnosis of anemia prior to elective surgeries is of great importance. Nonetheless, studies suggest that many opportunities to properly manage anemia in perioperative setting are lost. Patient blood management provides a framework of evidence-based strategies to effectively reduce the risk of occurrence of anemia and treat it with the ultimate goal of improving patient outcomes. Studies on the clinical impact of patient blood management strategies are emerging.
SUMMARY: Active screening for anemia and proper management of it in perioperative setting is essential. Several strategies to prevent anemia - including elimination of unnecessary diagnostic blood draws - are effective and reasonable approaches.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27022816     DOI: 10.1097/ACO.0000000000000340

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  2 in total

1.  Thresholds, triggers or requirements-time to look beyond the transfusion trials.

Authors:  Aryeh Shander; Tae-Yop Kim; Lawrence Tim Goodnough
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Anemia and acute coronary syndrome: current perspectives.

Authors:  Miriam Stucchi; Silvia Cantoni; Enrico Piccinelli; Stefano Savonitto; Nuccia Morici
Journal:  Vasc Health Risk Manag       Date:  2018-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.